EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US?
Introduction: Post-implantation syndrome (PIS) is the clinical and biochemical expression of an inflammatory response following endovascular repair of an aortic aneurysm (EVAR). The reported incidence in literature varies from 14-60%. Recentently, a study has demonstrated that red blood cell distribution width (RDW) is an independent biomarker predictor of the PIS in patients submitted to EVAR in the early postoperative period.
Methods: Retrospective institutional review of consecutive patients submitted to elective EVAR (January 2015- April 2020). The primary outcome was to evaluate the incidence of PIS, defined as fever (>38ºC) and leukocytosis (>12000/μL), excluding infection complication. The secondary outcomes were to identify the potential role of clinical and biomarker parameters to predict the risk of developing PIS after EVAR.
Results and conclusion: According to the inclusion criteria, 107 patients were identified. The median age was 75 years old (93.5% men). Comorbidities presented: hypertension (75%), smoking (66%), hypercholesterolemia (59%), coronary artery disease (32%), chronic kidney disease (30%), and diabetes mellitus (DM) (18%). The incidence of PIS was 10,2%. Age, gender and cardiovascular risk factors were found to be similar in both groups (P>0.05). Regarding the procedure approach, the majority of patients were treated with percutaneous access (72%) (P=0,49). In both groups (PIS vs. no PIS), the hemoglobin values significantly decreased (P=0,04) after surgery by approximately 14%. The same trend was observed for mean corpuscular volume (MCV) (P=0.032), which reflected the increasing of the RDW although not reaching statistical significance. Although delta variation of hemoglobin and delta RDW did not reach statistical significance comparing both groups (P=0,53 and P= 0,07 respectively), delta MCV was found to be significantly lower in the group with PIS (P=0.012). The importance of having a biomarker which measurement allows the prediction of patients who have more risk to develop PIS, may help with the early management of this condition.
2. Martinelli O, Di Girolamo A, Belli, C, Gattuso R et al. Incidence of Post-Implantation Syndrome with Different Endovascular Aortic Aneurysm Repair Modalities and Devices and Related Etiopathogenetic Implications. Ann Vasc Surg 2020 Feb;63:155-161
3. Arnaoutoglou E, Kouvelos G, Milionis H, et al. Post-implantation syndrome following endovascular abdominal aortic aneurysm repair: preliminary data. Interact Cardiovasc Thorac Surg 2011;12:609-14.
4. Swartbol P., Norgren L., Parsson H., Truedsson L. Endovascular abdominal aortic aneurysm repair induces significant alterations in surface adhesion molecule expression on donor white blood cells exposed to patient plasma. European Journal of Vascular and Endovascular Surgery. 1997;14(1):48–59.
5. Ferreira V, Machado R, Martins J, et al. Post-implantation syndromeeretrospective analysis of 52 patients. Angiol Cir Vasc 2015;11:204-8.
6. Chang CK, Chuter TA, Niemann CU, et al. Systemic inflammation, coagulopathy, and acute renal insufficiency following endovascular thoracoabdominal aortic aneurysm repair. J Vasc Surg 2009;49:1140-6.
7. Arnaoutoglou E, Kouvelos G, Papa N, et al. Prospective evaluation of post-implantation inflammatory response after EVAR for AAA: influence on patients' 30 day outcome. Eur J Vasc Endovasc Surg 2015;49:175-83.
8. Veraldi GF, Mezzetto L, Scorsone L, Macrì M, Bovo C, Simoncini F et al. Red blood cell distribution width (RDW) is an independent predictor of post-implantation syndrome in patients undergoing endovascular aortic repair for abdominal aortic aneurysm. Ann Transl Med 2018 Dec;6(23):453.
9. Voûte MT, Bastos Gonçalves FM, Van De Luijtgaarden KM, Klein Nulent CGA, Hoeks SE, Stolker RJ, et al. Stent graft composition plays a material role in the postimplantation syndrome. Journal of Vascular Surgery. 2012;56(6):1503-1509.
10. Nano G, Occhiuto MT, Stegher S, Malacrida G, Cova M, Righini P, et al. Postimplantation syndrome after endovascular aortic repair using the anacondaTM endograft. Annals of Vascular Surgery. 2014;28(6):1409-1415.
11. Kakisis JD, Moulakakis KG, Antonopoulos CN, Mylonas SN, Giannakopoulos TG, Sfyroeras GS, et al. Volume of new-onset thrombus is associated with the development of postimplantation syndrome after endovascular aneurysm repair. Journal of Vascular Surgery. 2014;60(5):1140-1145.
12. Kwon H, Ko G-Y, Kim M-J, Han Y, Noh M, Kwon T-W, et al. Effects of postimplantation systemic inflammatory response on long-term clinical outcomes after endovascular aneurysm repair of an abdominal aortic aneurysm. Medicine. 2016;95(32):e4532.
13. Swartbol P, Truedsson LNL. Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content. Journal of Vascular Surgery. 1998;28:664-668.
14. Barba R, Di Micco P, Blanco-Molina A, Delgado C, Cisneros EVJ. Fever and deep venous thrombosis. Findings from the RIETE registry. Journal of Thrombosis and Thrombolysis. 2011;32:288-292.
15. Videm V, Ødegård AMH. Iohexol-induced neutrophil myeloperoxidase release and activation upon contact with vascular stent-graft material: A mechanism contributing to the postimplantation syndrome. Journal of Endovascular Therapy. 2003;10:958-967 .
16. Omran M, Verma S, Lindsay TF, et al. Clinical decision making for endovascular repair of abdominal aortic aneurysm. Circulation 2004;110:e517-23.
17. Danese E, Lippi G, Montagnana M. Red blood cell distribution width and cardiovascular diseases. J Thorac Dis 2015;7:E402-11.